Drovix.
The Capacity Curve of Aggregated Liquidity: When One More LP Hurts
Market Analysis

The Capacity Curve of Aggregated Liquidity: When One More LP Hurts

More LPs is not always better. The capacity curve plateaus around 7-10 LPs on a major pair and turns negative beyond 12 — for measurable, mechanical reasons.

HomeResourcesInsights & News
22 May 2026Drovix Research Desk8 min

The intuition that more liquidity providers always make a counterparty's pricing better is wrong. The number of LPs on a panel has a capacity curve: pricing improves with the first few additions, plateaus through the middle, and degrades — measurably — past a particular point. The shape of the curve, and the specific point at which one more LP starts hurting, is one of the underrated engineering questions in institutional execution.

This piece is an account of the capacity-curve work Drovix has run over the last eighteen months on its connected LP panel, what the empirical curve actually looks like on a major institutional FX pair, and the specific mechanisms by which a marginal LP can produce a marginal negative — including the conditions under which a desk should ask its counterparty to drop an LP rather than add one.

An empty desert highway at dusk — capacity as horizon
An empty desert highway at dusk — capacity as horizon

The intuitive case for more LPs (and why it has limits)

With one LP, the desk pays the LP's quoted spread plus the LP's adverse-selection premium against the desk's flow signature. With two LPs, the desk routes the harder-to-fill clips to the cheaper venue and lets the easier clips fill on the better-quoted venue, and the average realised cost falls. With three LPs, the routing engine has more flexibility to allocate flow conditional on size, urgency and recent LP behaviour, and the average cost falls again.

This logic continues. With five LPs the routing has access to four-way price competition on every clip, with three of the five LPs being secondary candidates for the worst-case fill. By seven or eight LPs, the marginal improvement per added LP is small but still positive on a typical liquid major. By twelve LPs on the same major, the marginal improvement has reached zero. Past fifteen, on average, it has gone negative.

Why the curve eventually turns negative

Three mechanisms drive the negative slope at the high end of the curve.

First: the cost of message-rate management. Each connected LP delivers a continuous market-data stream. The aggregation engine must consume, normalise and merge those streams at the throughput rate of the slowest critical path. Past a certain number of LPs, the aggregation latency per market-data tick rises, the engine's decision time on each clip slightly extends, and the queue-position premium starts to leak. The leak is small per clip but consistent.

Second: the cost of LP-specific calibration. The routing engine maintains per-LP behavioural models: reject distributions, mark-out curves, recent fill quality, conditional adjustments per regime. Each LP requires statistical power to maintain its model with low variance. The desk's total flow is finite; spreading it across more LPs reduces the flow per LP, increases the variance of each LP's model, and degrades the routing engine's per-clip decision quality.

Third: the cost of LP toxicity correlation. Marginal LPs added at the long tail of the panel are often LPs whose stress behaviour correlates with each other — typically smaller specialist non-bank market makers whose risk capacity scales together in a stress. Adding them in normal times produces marginal tightening of top-of-book; in a stress, they all withdraw together, leaving the panel suddenly thinner than expected. The realised cost of the correlation hits in exactly the conditions the desk needed the depth most.

The empirical curve on a major pair

On EUR/USD, across the last 18 months of Drovix's panel performance, the empirical capacity curve as a function of connected LP count is roughly: average realised spread improves by ~0.25 pips from one LP to four, by a further ~0.10 pips from four to seven, by ~0.04 pips from seven to ten, and is essentially flat thereafter. Past twelve LPs, the curve begins to slope upward at roughly 0.01 pips per added LP, attributable to the three mechanisms above.

On thinner pairs — say USD/MXN or AUD/CAD — the curve plateaus earlier and turns negative sooner. The effective panel for a typical EM cross is six to eight LPs; adding more produces no measurable improvement and adds calibration noise.

On a major equity index CFD, the curve is shaped similarly but with a different inflection point — six to ten LPs is typically the productive range, with the optimal panel size depending heavily on the LPs' inventory horizons and overnight risk policies.

When a desk should ask the counterparty to drop an LP

The capacity curve implies that an actively-managed panel has churn. Adding an LP that improves the panel's pricing is the obvious half. Dropping an LP that no longer earns its keep is the half that almost nobody does.

A desk should consider asking its counterparty to drop an LP from its share of the panel when (a) the LP's realised mark-out against the desk's flow has drifted negative for more than two months, (b) the LP's reject rate has risen materially or asymmetric-last-look signatures have emerged, (c) the LP's conditional widening on news events has grown disproportionate to its peers, or (d) the LP's correlation with another LP on the panel — measured by joint behaviour in stress windows — has risen above an explicit threshold.

None of these conditions imply that the LP is doing anything wrong. They imply that, for this desk, the LP is no longer at the productive part of the desk's capacity curve. The counterparty should be able to drop the LP from the desk's panel without disrupting the desk's overall execution; that is a feature of a real aggregation layer.

A glass funnel narrowing to a point — productive panel size as engineered constraint
A glass funnel narrowing to a point — productive panel size as engineered constraint

How Drovix manages the panel

Drovix maintains a curated panel of bank and non-bank LPs, with documented per-LP performance against the metrics described above, reviewed quarterly. The curation includes both additions and removals; an LP whose performance has drifted out of the productive range is removed rather than carried as a marketing add-on.

The desk's per-counterparty panel is configurable within the curated set: a specific counterparty can request a narrower panel, exclude specific LPs, or request a panel weighted toward certain LP types. Each configuration is reflected in the counterparty's TCA, with the realised effects of the panel choice attributable per-LP.

The point is not that more LPs is always better. The point is that the optimal panel is a finite set, that it changes over time, and that the counterparty's job is to make those changes on behalf of the desk without churning the desk's connectivity or operational state. The capacity curve is the empirical justification for treating panel management as a managed product rather than a fixed feature.

The structural implication of capacity-curve thinking for diligence on a new counterparty is in counterparty concentration risk, and the implication for the routing engine itself sits next to queue-position economics.

Methodology and data

The capacity curve is the relationship between cumulative notional executed on a single ladder sweep and the realised slippage at each notional. Curves are constructed from Drovix's aggregated tier-1 panel across nine majors over the trailing twelve months, in 1M-notional increments up to 100M, then 5M increments to 500M. Each point is the median of at least 200 sweeps in conditions matched on time-of-day and prevailing 1-min realised vol.

Limitations and scope

The curve is descriptive of normal conditions. In stress, the curve translates upward (higher slippage at every notional) AND shifts left (the inflection point at which slippage explodes moves toward smaller sizes). Curves are not additive across instruments — a desk sweeping correlated names sees worse blended slippage than the sum of single-instrument curves would predict.

Further reading

→ Capacity Planning for Execution Strategies — How desks budget against the curve at the strategy level. See /blog/capacity-planning-for-execution-strategies.

→ Architecture of a Fair Spread — Where capacity sits in the wider pricing stack. See /blog/architecture-of-a-fair-spread.

Drovix Research is the in-house institutional desk of Drovix MU Ltd, regulated by the Financial Services Commission of Mauritius. All notes are informational only and do not constitute investment advice, a solicitation, or a recommendation to transact in any financial instrument.

Analyst Desk

Drovix Research Desk

Institutional Research

Drovix Research Desk publishes institutional-grade analysis covering macro events, cross-asset correlations, and execution insights for professional market participants.

Frequently Asked Questions

Q1.Where is the inflection point on EUR/USD?+
On the studied panel in normal conditions, the curve is roughly linear up to about 25M notional per single sweep, then convexes. By 100M, marginal slippage is approximately three times the average from the first 25M. Exact numbers are panel-specific and worth re-running on your own tape.
Q2.How does aggregation help?+
A flat aggregation summing top-of-book across LPs is the floor. A smart aggregation that reconstructs synthetic depth and routes consecutive child clips across LPs to minimise self-impact is the ceiling. The gap between floor and ceiling is the main capacity advantage of a serious aggregator.
Q3.Can I see my own curve?+
Yes — Drovix produces a per-counterparty capacity curve from real fills as part of the standard institutional reporting package. Counterparties can also request a what-if curve against a different notional schedule before committing to a strategy change.

Related Reads

Market Analysis

Prime-of-Prime vs Tier-1 Direct: Choosing the Right Liquidity Stack

Next Read

Market Analysis

The Anatomy of an Effective Spread: A 2026 Microstructure Survey

Next Read

Market Analysis

Asymmetric Last Look: Where the Rejection Bias Hides in Plain Sight

Next Read

Back to Insights
Drovix.

Institutional-grade liquidity, connectivity, and analytics for professional market participants worldwide.

About

  • Why Drovix
  • About Us
  • Technology
  • For Brokers
  • For Hedge Funds & Quants
  • For Family Offices
  • For Prop Trading Firms
  • For Institutions & Corporates
  • DVX Trading Platform
  • Institutional Liquidity
  • Market Making
  • Contact
  • Insights

Compliance

  • Client Eligibility
  • Risk & Controls
  • Regulation
  • Regulatory Status
  • Restricted Jurisdictions
  • Reverse Solicitation
  • Risk Disclosure

Legal

  • Privacy
  • Terms and Agreements
  • Client Agreement
  • Order Execution Policy
  • AML/KYC Policy
  • Cookie Policy
  • Complaints Handling
  • Site map

Professional & Institutional Clients Only: Drovix provides services only to approved professional clients, eligible counterparties and institutional clients where permitted by applicable law. Drovix does not provide services to retail clients through this website and does not accept public deposits or retail deposits.

FSC Mauritius: Drovix (MU) Ltd is authorised and regulated by the Financial Services Commission of Mauritius as an Investment Dealer (Full Service Dealer excluding Underwriting), licence number GB21026813. Regulatory authorisations apply only to the legal entity to which they are granted and do not extend automatically to any affiliated entity, offshore entity, group company or retail-facing brand. Drovix is not currently authorised by the UK Financial Conduct Authority.

No Public / Retail Deposits: Drovix is not a bank and does not accept public deposits or retail deposits. Where margin, collateral or client money is held in connection with an approved institutional relationship, it is handled in accordance with applicable regulatory requirements and the relevant client agreement. Client funds held with Drovix (MU) Ltd are not protected by any government deposit guarantee or investor compensation scheme; the Financial Services Commission of Mauritius does not operate an investor compensation fund.

The information on this website is intended for approved professional clients, eligible counterparties and institutional clients only. It does not constitute investment advice, a solicitation or a recommendation to enter into any transaction. Drovix is not a public exchange, multilateral trading facility (MTF), organised trading facility (OTF), ECN, retail trading venue or retail broker. Drovix may act as principal in bilateral OTC transactions, or arrange the transmission of orders to third-party liquidity providers, in order to maintain best execution under prevailing market conditions.

Reverse Solicitation Notice: The information and services on this website are not directed at or intended for distribution to residents or nationals of any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Approved institutional counterparties access Drovix (MU) Ltd services on their own initiative. Reverse-solicitation arguments cannot be used to bypass retail rules, sanctions or applicable cross-border regulation.

Drovix services are not intended for residents, nationals or entities located in jurisdictions where Drovix is not authorised or permitted to provide services. Restricted jurisdictions include, but are not limited to: Afghanistan, Australia, Barbados, Belarus, Belgium, Burkina Faso, Cameroon, Canada, Central African Republic, Cuba, Democratic Republic of Congo, France, Haiti, Iran, Japan, Libya, Malaysia, Mali, Mozambique, Myanmar, Nicaragua, North Korea, Poland, Russia, Senegal, Sudan, Syria, Tanzania, Ukraine, the United Kingdom, the United States, Venezuela, Yemen and Zimbabwe, together with all jurisdictions on applicable EU, UN, UK, US OFAC and Mauritius sanctions lists. See Restricted Jurisdictions for the full list and policy.

© 2026 Drovix (MU) Ltd. All rights reserved.

Drovix (MU) Ltd is authorised and regulated by the Financial Services Commission (FSC) of Mauritius as an Investment Dealer (Full Service Dealer) under licence number GB21026813.

Drovix (MU) Ltd is not authorised by the United Kingdom Financial Conduct Authority and is not registered with the U.S. SEC, CFTC or NFA. Nothing on this website constitutes a financial promotion under section 21 of the UK Financial Services and Markets Act 2000.

The company operates under drovix.com and is registered at C/o SALVUS (Mauritius) Ltd, Silver Bank Tower, Ground Floor, 18 Bank Street, Cybercity, Ebene 72201 Mauritius.